Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Current Targeted Therapy for Metastatic Colorectal Cancer

Version 1 : Received: 17 February 2022 / Approved: 21 February 2022 / Online: 21 February 2022 (03:05:05 CET)

How to cite: Ohishi, T.; Kaneko, M.K.; Yoshida, Y.; Kato, Y.; Kawada, M. Current Targeted Therapy for Metastatic Colorectal Cancer. Preprints 2022, 2022020242 (doi: 10.20944/preprints202202.0242.v1). Ohishi, T.; Kaneko, M.K.; Yoshida, Y.; Kato, Y.; Kawada, M. Current Targeted Therapy for Metastatic Colorectal Cancer. Preprints 2022, 2022020242 (doi: 10.20944/preprints202202.0242.v1).

Abstract

Colorectal cancer (CRC) is the third most common type of cancer and the second leading cause of cancer deaths worldwide. Surgery or surgery plus radiotherapy and/or chemotherapy for patients with metastatic CRC (mCRC) were accepted as the main therapeutic strategies until the early 2000s, when targeted drugs, like cetuximab and bevacizumab were developed. The use of targeted drugs in clinical practice has significantly increased patients’ overall survival. To date, the emergence of several types of targeted drugs has opened new possibilities and revealed new prospects for mCRC treatment. Therapeutic strategies are continually being updated to select the most suitable targeted drugs based on the results of clinical trials that are currently underway. This review discusses the up-to date molecular evidence of targeted therapy for mCRC and summarizes the Food and Drug Administration-approved targeted drugs including the results of clinical trials. We also explain their mechanisms of action and how these affect the choice of a suitable targeted therapy.

Keywords

Colorectal cancer; Targeted therapy; Clinical trial

Subject

MEDICINE & PHARMACOLOGY, Oncology & Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.